Foreign investment
-
Economy
Glaxo Smith Kline has a billion dollars to spare
A note on GSK paying about $1.05 billion to raise its stake in its Indian unit to 75 per cent, with the poster asking how that fits with patent disputes…
The Indian Subcontinent Argues with Itself